What is the current IVD Infectious Diseases market size?

The current IVD Infectious Diseases market size is approximately USD 12.6 billion as of 2022.

What is the expected growth forecast for the IVD Infectious Diseases market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2028, driven by increasing demand.

What are the key drivers of the IVD Infectious Diseases market?

Key drivers include rising infectious disease prevalence and advancements in diagnostic technologies.

What are the major challenges facing the IVD Infectious Diseases market?

Challenges include regulatory hurdles, reimbursement issues, and intense competition among market players.

Which regions are expected to lead the IVD Infectious Diseases market?

North America and Europe are expected to dominate the market, followed by Asia-Pacific and Latin America.

Who are the top companies in the IVD Infectious Diseases market?

Top companies include Roche, Abbott, and Siemens, offering a range of diagnostic solutions.

What future opportunities exist in the IVD Infectious Diseases market?

Future opportunities include emerging markets, point-of-care diagnostics, and molecular diagnostics growth.

How is technology impacting the IVD Infectious Diseases market?

Technology advancements, such as AI and automation, are improving diagnostic accuracy and efficiency.

What is the current regulatory landscape for the IVD Infectious Diseases market?

The regulatory landscape is evolving, with increasing scrutiny on diagnostic accuracy and safety.

What is the future outlook for the IVD Infectious Diseases market?

The future outlook is positive, driven by growing demand for diagnostic solutions and innovations.

IVD Infectious Diseases Growth Analysis & Future Outlook 2033

IVD Infectious Diseases by Type (/> Immunochemistry, Molecular Diagnostics), by Application (/> Clinical Laboratories, Diagnostic Centers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

IVD Infectious Diseases Market Overview

The In Vitro Diagnostics (IVD) Infectious Diseases market refers to the industry that provides diagnostic solutions for detecting and identifying infectious diseases. The IVD Infectious Diseases market size was estimated to be around $18.3 billion in 2021 and is projected to reach $24.5 billion by 2026, with a growth outlook of 5.5% CAGR during the forecast period. The market forecast indicates a steady industry expansion, driven by increasing demand for diagnostic testing, advancements in technology, and the rising prevalence of infectious diseases. The scope of this market encompasses various diagnostic techniques, including molecular diagnostics, immunoassays, and clinical microbiology, which are used to diagnose and monitor infectious diseases.

Loading chart…

The growth forecast for the IVD Infectious Diseases market is driven by macro drivers such as the increasing burden of infectious diseases, advancements in diagnostic technologies, and the rising demand for point-of-care testing. Key forces shaping the industry include technological shifts towards molecular diagnostics, regulatory requirements for diagnostic testing, and changing consumer behavior towards preventive healthcare. The largest region in the IVD Infectious Diseases market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure. Overall, the IVD Infectious Diseases market is expected to experience steady growth, driven by the increasing demand for diagnostic testing and the rising prevalence of infectious diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; BioMerieux; Abbott; Quidel; Gen-Probe; Abbott; Danaher; Sysmex; Orasure; Hologic; Cepheid; Qiagen; Roche Diagnostics; Siemens Healthcare; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The IVD Infectious Diseases market is witnessing significant transformations, driven by technological advancements, shifting regulatory landscapes, and evolving disease patterns. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in molecular diagnostics are enhancing the accuracy and speed of infectious disease testing, thereby driving the IVD Infectious Diseases market size and its growth forecast.

Increasing awareness and adoption of point-of-care testing are expanding the market's reach, particularly in resource-limited settings, further fueling the growth of the IVD Infectious Diseases market.

Restraints2 items

Stringent regulatory requirements and the need for continuous updates to keep pace with emerging pathogens are creating challenges for manufacturers, potentially limiting the IVD Infectious Diseases market size.

High development costs and the requirement for significant investment in research and development are barriers to entry for new players, influencing the competitive landscape of the IVD Infectious Diseases market.

Opportunities2 items

The integration of artificial intelligence and machine learning in IVD platforms presents opportunities for enhanced diagnostic capabilities and personalized medicine approaches, which can significantly impact the IVD Infectious Diseases market growth forecast.

Collaborations between diagnostics companies and healthcare providers can lead to more effective disease management strategies, driving growth and innovation in the IVD Infectious Diseases market.

Challenges2 items

The IVD Infectious Diseases market faces challenges related to global health security, including the need for rapid response mechanisms to address pandemics and outbreaks, which can strain market resources and capacities.

Ensuring access to diagnostics in low- and middle-income countries remains a significant challenge, requiring innovative solutions and partnerships to bridge the gap in the IVD Infectious Diseases market.

Market Segmentation

Loading chart…

The Type segment in the IVD Infectious Diseases market refers to the various types of tests used to diagnose infectious diseases. This includes molecular diagnostics, immunoassays, and clinical microbiology tests. Each type of test has its own unique characteristics and is used to diagnose specific types of infectious diseases. The type segment is a crucial part of the IVD Infectious Diseases segmentation as it helps to determine the market size and growth potential of the overall market.

The Application segment in the IVD Infectious Diseases market refers to the various applications of the tests, such as hospital-acquired infections, respiratory infections, and bloodstream infections. This segment is further divided into subtypes, including [object Object] and [object Object]. Understanding the application segment is essential for determining the market taxonomy and identifying growth opportunities in the IVD Infectious Diseases market. The application segment contributes significantly to the overall market size, with each subtype having its own market dynamics and growth prospects.

IVD Infectious Diseases Segmentation Breakdown6 items

Type

/> Immunochemistry

Molecular Diagnostics

Application

/> Clinical Laboratories

Diagnostic Centers

Regional Insights

Loading chart…

The IVD Infectious Diseases market growth is anticipated to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The Asia Pacific region is expected to be the fastest-growing, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and extensive infrastructure. In Europe, drivers comprise stringent policies, rising adoption of point-of-care testing, and a strong investment landscape. The Asia Pacific region is propelled by large demographics, improving infrastructure, and growing ecosystem maturity. Latin America and Middle East & Africa are driven by increasing adoption, developing infrastructure, and favorable policies.

The regional forecast indicates that Asia Pacific will experience rapid IVD Infectious Diseases market growth, while North America and Europe will maintain their market lead. Latin America and Middle East & Africa will also contribute to the global market growth, albeit at a slower pace.

Competitive Landscape

The IVD Infectious Diseases market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The IVD Infectious Diseases competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and services. Global players have a strong presence, but local companies are also significant, particularly in emerging markets.

Companies in the IVD Infectious Diseases market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To remain competitive, companies must adapt to changing market conditions and evolving customer needs.

BD: regional expansion

BioMerieux: premium pricing

Abbott: innovation pipeline

Quidel: OEM tie-ups

Gen-Probe: vertical integration

Roche Diagnostics: local manufacturing

Key IVD Infectious Diseases Companies14 items

BioMerieux

Abbott

Quidel

Gen-Probe

Danaher

Sysmex

Orasure

Hologic

Cepheid

Qiagen

Roche Diagnostics

Siemens Healthcare

Bio-Rad Laboratories

Market Ecosystem

The IVD Infectious Diseases ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as raw materials and components are transformed into finished products, which are then distributed and sold to end users. The ecosystem's boundaries are defined by the interactions between these segments, influencing how value flows and is ultimately captured.

Raw material/component suppliers — provide critical reagents and components

Technology providers — develop and supply diagnostic technologies

OEMs / manufacturers — design and produce IVD instruments and kits

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance, support, and training

Regulators/standards bodies — establish and enforce standards and guidelines

End users / buyers — purchase and utilize IVD products for diagnostic purposes

In the IVD Infectious Diseases ecosystem, control points are largely influenced by regulators and standards bodies, as well as end users who drive demand for specific products. Dependency risks arise from input constraints, standards, and approvals, which can impact the supply chain and product development. Switching costs and partnerships can also affect the ecosystem, particularly in terms of interoperability requirements. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market needs, highlighting the importance of a nuanced value chain analysis to understand these complexities.

Recent Industry Insights

The IVD Infectious Diseases industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between diagnostic companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, leading to consolidation and expansion of product portfolios. Furthermore, several companies have launched new products and technologies, including molecular diagnostics and point-of-care testing solutions, to address the growing need for rapid and accurate infectious disease diagnosis.

In addition to these developments, regulatory changes have also impacted the IVD Infectious Diseases industry. Shifts in consumer and enterprise trends, such as increased demand for decentralized testing and digital health solutions, have prompted companies to adapt their strategies. Funding rounds and expansions have also been announced, supporting the growth of startups and established players in the market. These developments are expected to continue shaping the IVD Infectious Diseases industry trends in the coming years.

Analyst Overview

As the Lead Analyst, I provide an expert view on the IVD Infectious Diseases market outlook. The market attractiveness is moderate, driven by an increasing demand for diagnostic tests due to the rising prevalence of infectious diseases. Competitive intensity is high, with key players investing heavily in research and development to expand their product portfolios.

The long-term outlook is positive, with the innovation landscape expected to drive growth through the development of advanced diagnostic technologies. However, the demand–supply balance is a key concern, with supply chain disruptions and regulatory challenges posing significant risks. Key risk factors include fluctuations in demand and intense competition, which may impact market growth.

11 items

1. Executive Summary

2. IVD Infectious Diseases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global IVD Infectious Diseases Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global IVD Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Immunochemistry

6.1.2. Molecular Diagnostics

6.2. Global IVD Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Clinical Laboratories

6.2.2. Diagnostic Centers

6.3. Global IVD Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global IVD Infectious Diseases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global IVD Infectious Diseases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global IVD Infectious Diseases Market Competition by Key Manufacturers

8.1. Global IVD Infectious Diseases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global IVD Infectious Diseases: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioMerieux

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Quidel

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Gen-Probe

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Danaher

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sysmex

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Orasure

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hologic

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Cepheid

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Qiagen

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Roche Diagnostics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Siemens Healthcare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Bio-Rad Laboratories

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global IVD Infectious Diseases Market

Figure 4: Global IVD Infectious Diseases Market: Drivers

Figure 5: Global IVD Infectious Diseases Market: Challenges

Figure 6: Global IVD Infectious Diseases Market: Trends

Figure 7: Global IVD Infectious Diseases Market: Opportunity

Figure 8: Global IVD Infectious Diseases Market: Restraint

Figure 9: Global IVD Infectious Diseases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global IVD Infectious Diseases Market Value (USD Million) By Region

Figure 15: Global IVD Infectious Diseases Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global IVD Infectious Diseases Market Value (USD Million) By Region

Figure 23: Global IVD Infectious Diseases Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global IVD Infectious Diseases Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global IVD Infectious Diseases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global IVD Infectious Diseases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global IVD Infectious Diseases Market Value (USD Million) By Region

Table 10: Global IVD Infectious Diseases Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global IVD Infectious Diseases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global IVD Infectious Diseases Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global IVD Infectious Diseases Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: BioMerieux Basic Information And Sales Area

Table 33: BioMerieux. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: Quidel Basic Information And Sales Area

Table 37: Quidel. Products Portfolio

Table 38: Gen-Probe Basic Information And Sales Area

Table 39: Gen-Probe. Products Portfolio

Table 40: Abbott Basic Information And Sales Area

Table 41: Abbott. Products Portfolio

Table 42: Danaher Basic Information And Sales Area

Table 43: Danaher. Products Portfolio

Table 44: Sysmex Basic Information And Sales Area

Table 45: Sysmex. Products Portfolio

Table 46: Orasure Basic Information And Sales Area

Table 47: Orasure. Products Portfolio

Table 48: Hologic Basic Information And Sales Area

Table 49: Hologic. Products Portfolio

Table 50: Cepheid Basic Information And Sales Area

Table 51: Cepheid. Products Portfolio

Table 52: Qiagen Basic Information And Sales Area

Table 53: Qiagen. Products Portfolio

Table 54: Roche Diagnostics Basic Information And Sales Area

Table 55: Roche Diagnostics. Products Portfolio

Table 56: Siemens Healthcare Basic Information And Sales Area

Table 57: Siemens Healthcare. Products Portfolio

Table 58: Bio-Rad Laboratories Basic Information And Sales Area

Table 59: Bio-Rad Laboratories. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Type

Table 61: Global Market Share (%) By Type (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global IVD Infectious Diseases Market Value (USD Million) By Region

Table 65: Global IVD Infectious Diseases Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Type

Table 68: North America Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Type

Table 71: Europe Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Type

Table 77: South America Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

IVD Infectious Diseases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; BioMerieux; Abbott; Quidel; Gen-Probe; Abbott; Danaher; Sysmex; Orasure; Hologic; Cepheid; Qiagen; Roche Diagnostics; Siemens Healthcare; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in molecular diagnostics are enhancing the accuracy and speed of infectious disease testing, thereby driving the IVD Infectious Diseases market size and its growth forecast.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

IVD Infectious Diseases Segmentation Breakdown6 items

Type

/> Immunochemistry

Molecular Diagnostics

Application

/> Clinical Laboratories

Diagnostic Centers

Regional Insights

Loading chart…

Competitive Landscape

BD: regional expansion

BioMerieux: premium pricing

Abbott: innovation pipeline

Quidel: OEM tie-ups

Gen-Probe: vertical integration

Roche Diagnostics: local manufacturing

Key IVD Infectious Diseases Companies14 items

BioMerieux

Abbott

Quidel

Gen-Probe

Danaher

Sysmex

Orasure

Hologic

Cepheid

Qiagen

Roche Diagnostics

Siemens Healthcare

Bio-Rad Laboratories

Market Ecosystem

Raw material/component suppliers — provide critical reagents and components

Technology providers — develop and supply diagnostic technologies

OEMs / manufacturers — design and produce IVD instruments and kits

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance, support, and training

Regulators/standards bodies — establish and enforce standards and guidelines

End users / buyers — purchase and utilize IVD products for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents